1. Home
  2. GBIO vs FCCO Comparison

GBIO vs FCCO Comparison

Compare GBIO & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • FCCO
  • Stock Information
  • Founded
  • GBIO 2016
  • FCCO 1994
  • Country
  • GBIO United States
  • FCCO United States
  • Employees
  • GBIO N/A
  • FCCO N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • FCCO Major Banks
  • Sector
  • GBIO Health Care
  • FCCO Finance
  • Exchange
  • GBIO Nasdaq
  • FCCO Nasdaq
  • Market Cap
  • GBIO 145.5M
  • FCCO 166.4M
  • IPO Year
  • GBIO 2020
  • FCCO 1998
  • Fundamental
  • Price
  • GBIO $2.50
  • FCCO $21.31
  • Analyst Decision
  • GBIO Buy
  • FCCO Buy
  • Analyst Count
  • GBIO 4
  • FCCO 1
  • Target Price
  • GBIO $7.50
  • FCCO $21.00
  • AVG Volume (30 Days)
  • GBIO 63.3K
  • FCCO 18.5K
  • Earning Date
  • GBIO 08-07-2024
  • FCCO 10-16-2024
  • Dividend Yield
  • GBIO N/A
  • FCCO 2.81%
  • EPS Growth
  • GBIO N/A
  • FCCO N/A
  • EPS
  • GBIO N/A
  • FCCO 1.42
  • Revenue
  • GBIO $13,174,000.00
  • FCCO $59,227,000.00
  • Revenue This Year
  • GBIO $99.36
  • FCCO N/A
  • Revenue Next Year
  • GBIO N/A
  • FCCO $9.86
  • P/E Ratio
  • GBIO N/A
  • FCCO $15.04
  • Revenue Growth
  • GBIO 1397.05
  • FCCO N/A
  • 52 Week Low
  • GBIO $0.86
  • FCCO $15.40
  • 52 Week High
  • GBIO $4.65
  • FCCO $23.30
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 49.32
  • FCCO 52.82
  • Support Level
  • GBIO $2.13
  • FCCO $20.50
  • Resistance Level
  • GBIO $2.49
  • FCCO $22.20
  • Average True Range (ATR)
  • GBIO 0.21
  • FCCO 0.59
  • MACD
  • GBIO 0.01
  • FCCO -0.09
  • Stochastic Oscillator
  • GBIO 46.91
  • FCCO 46.07

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About FCCO First Community Corporation

First Community Corp is a bank holding company, which provides commercial banking services. It is engaged in the general commercial and retail banking business characterized by personalized service and local decision making, emphasizing the banking needs of small to medium-sized businesses, professional concerns, and individuals. It operates through following segments: Commercial and Retail Banking; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate. It offers checking, savings, money market, individual retirement, and certificates of deposit accounts. Its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others.

Share on Social Networks: